NCT00689767View on ClinicalTrials.gov

COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1)

NATerminatedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2012

Conditions
Coronary Artery Disease
Interventions
DEVICE

CINATRA™ Coronary Stent System

Bare metal cobalt chromium stent implantation

DEVICE

CINATRA™ ISA 247 Coated Coronary Stent System

Drug coated cobalt chromium stent implantation

Trial Locations (7)

1200

Cliniques universitaires Saint-Luc, Brussels

2820

Imelda ziekenhuis, Bonheiden

3000

UZ Leuven Cardiovascular Institute, Leuven

3500

Virga Jesse Ziekenhuis, Hasselt

3600

Ziekenhuis Oost Limburg, Campus Sint Jan, Genk

9000

Algemeen Ziekenhuis Maria Middelares, Ghent

Unknown

Middelheim Hospital, Antwerp

Sponsors
All Listed Sponsors
lead

Atrium Medical Corporation

INDUSTRY

NCT00689767 - COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1) | Biotech Hunter | Biotech Hunter